Regulus Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Regulus Therapeutics Inc
TickerRGLS
CIK #0001505512
CUSIP75915K101
SectorLife Sciences - Pharmaceutical Preparations
Address3545 John Hopkins Court Suite 210, San Diego, CA 92121
Source [EDGAR]
CIK Filing 2011 - 2025
[0001505512] 10-K
[0001505512] 10-Q
[0001505512] 3
[0001505512] 4
[0001505512] 8-K
[0001505512] D
[0001505512] SC 13D
[0001505512] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
FMR LLC Regulus Therapeutics Inc [2022-10-11] 0.0
Federated Hermes Inc Regulus Therapeutics Inc [2022-05-16] 19.9
Victory Capital Management Inc Regulus Therapeutics Inc [2021-03-08] 12.73
Point72 Asset Management LP Regulus Therapeutics Inc [2020-12-09] 8.5
EcoR1 Capital LLC Regulus Therapeutics Inc [2020-01-03] 0.99
Sarissa Capital Management LP Regulus Therapeutics Inc [2019-05-17] 16.53
Altium Capital Management LP Regulus Therapeutics Inc [2019-05-17] 9.99
Growth Equity Opportunities V LLC Regulus Therapeutics Inc [2017-08-02] 11.3
Broadfin Capital LLC Regulus Therapeutics Inc [2017-07-24] 5.65
EcoR1 Capital LLC Regulus Therapeutics Inc [2017-05-30] 0.6
Biotechnology Value Fund L P Regulus Therapeutics Inc [2017-05-05] 2.8
UBS Asset Management Americas Inc Regulus Therapeutics Inc [2016-02-16] 5.43
Foresite Capital Fund II LP Regulus Therapeutics Inc [2016-02-05] 3.6
Foresite Capital Fund II LP Regulus Therapeutics Inc [2015-09-09] 3.85
Wellington Management Group LLP Regulus Therapeutics Inc [2015-02-12] 7.78
RA Capital Management LLC Regulus Therapeutics Inc [2014-11-07] 0.8
FMR LLC Regulus Therapeutics Inc [2013-07-10] 0.0
Alnylam Pharmaceuticals Inc Regulus Therapeutics Inc [2013-02-14] 17.2
ISIS Pharmaceuticals Inc Regulus Therapeutics Inc [2012-10-19] 11.0
Biotechnology Value Fund L P Regulus Therapeutics Inc [2012-10-15] 5.6
Astrazeneca PLC Regulus Therapeutics Inc [2012-10-12] 18.3
GlaxoSmithKline PLC Regulus Therapeutics Inc [2012-10-10] 0.3
Sanofi Regulus Therapeutics Inc [2012-10-09] 10.99
Form 3/4/5 Filer 2011 - 2025
Papadopoulos Stelios
Regulus Therapeutics Inc.
Baltimore David
Collier Kathryn J
Huang Alice Shih-hou
Nunn Jason Raleigh
Witz Pascale
Rosen Hugh
Rastetter William H
Klassen Preston
Hagan Joseph P
Calsada Crispina
Aker Christopher Ray
Simeonidis Simos
Drygin Denis
Baskett Forest
NEA Partners 16, L.P.
NEA 16 GP LLC
Growth Equity Opportunities V, LLC
New Enterprise Associates 16, L.P.
Chang Carmen
Florence Anthony A. Jr.
Behbahani Ali
Walker Paul Edward
Sonsini Peter W.
Sandell Scott D
Makower Joshua
Makhzoumi Mohamad
Sarissa Capital Offshore Master Fund LP
Sarissa Capital Master Fund II LP
Sarissa Capital Management LP
Sarissa Capital Hawkeye Fund LP
Sarissa Capital Catapult Fund LLC
Denner Alexander J
Mott David M
Barris Peter J
Chevallard Daniel R.
Wright Timothy Michael
Deeg Mark Albert
Foletta Mark G
Lampert Mark N
Biotechnology Value Fund II LP
BVF Partners OS Ltd.
BVF Inc/IL
BVF Partners L P/IL
Biotechnology Value Trading Fund OS LP
Biotechnology Value Fund L P
Viswanathan Ravi
Sakoda Jon
Puttagunta Chetan
Grint Paul C
Williams Douglas E
Alnylam Pharmaceuticals Inc
Ionis Pharmaceuticals Inc
Carter Bruce L A
Xanthopoulos Kleanthis G
Gibson Neil W
Szekeres David Leslie
Astrazeneca PLC
Astrazeneca AB
Parshall B Lynne
Sanofi
Menzel Garry E
Crooke Stanley T
Greene Barry E
Maraganore John
Form 13F Holdings
Firm Period DFND Voting Shares
NEA Management Company LLC [2023-03-31] DFND 1,445,114.0 1,445,114.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com